Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial
Hamdi Jama, Dakota Rhys‐Jones, Michael Nakai, et al.
Nature Cardiovascular Research (2023) Vol. 2, Iss. 1, pp. 35-43
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

The gut microbiome and hypertension
Joanne A. O’Donnell, Tenghao Zheng, Guillaume Méric, et al.
Nature Reviews Nephrology (2023) Vol. 19, Iss. 3, pp. 153-167
Closed Access | Times Cited: 129
Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension
Fadi J. Charchar, Priscilla R. Prestes, Charlotte Mills, et al.
Journal of Hypertension (2023) Vol. 42, Iss. 1, pp. 23-49
Open Access | Times Cited: 86
Immune and inflammatory mechanisms in hypertension
Tomasz J. Guzik, Ryszard Nosalski, Pasquale Maffia, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 6, pp. 396-416
Closed Access | Times Cited: 81
A major mechanism for immunomodulation: Dietary fibres and acid metabolites
Liang Xie, Jahangir Alam, Francine Z. Marques, et al.
Seminars in Immunology (2023) Vol. 66, pp. 101737-101737
Open Access | Times Cited: 47
The Gut–Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics
Georgia Saxami, Evangelia N. Kerezoudi, Christos Eliopoulos, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2023-2023
Open Access | Times Cited: 27
The role of dietary salt in metabolism and energy balance: Insights beyond cardiovascular disease
Qi Wu, George Burley, Licheng Li, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 5, pp. 1147-1161
Open Access | Times Cited: 22
Short‐Chain Fatty Acid Butyrate Is an Inotropic Agent With Vasorelaxant and Cardioprotective Properties
Jacob Seefeldt, Casper Homilius, Jakob Hansen, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 9
Open Access | Times Cited: 10
The gut–immune axis during hypertension and cardiovascular diseases
Evany Dinakis, Joanne A. O’Donnell, Francine Z. Marques
Acta Physiologica (2024) Vol. 240, Iss. 8
Open Access | Times Cited: 10
Recommendations for the Use of Dietary Fiber to Improve Blood Pressure Control
Hamdi Jama, Matthew Snelson, Aletta E. Schutte, et al.
Hypertension (2024) Vol. 81, Iss. 7, pp. 1450-1459
Closed Access | Times Cited: 9
Influence of angiotensin II on the gut microbiome: modest effects in comparison to experimental factors
Rikeish R. Muralitharan, Michael Nakai, Matthew Snelson, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 10, pp. 1155-1163
Open Access | Times Cited: 8
Gut Microbiota Alterations in Patients With Kawasaki Disease
Prasant Kumar Jena, Moshe Arditi, Magali Noval Rivas
Arteriosclerosis Thrombosis and Vascular Biology (2025)
Closed Access | Times Cited: 1
Microbiome-targeted interventions for the control of oral–gut dysbiosis and chronic systemic inflammation
Juan Pacheco‐Yanes, Eric C. Reynolds, Jian Li, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 11, pp. 912-925
Closed Access | Times Cited: 18
Novel mechanisms of salt-sensitive hypertension
Liffert Vogt, Francine Z. Marques, Toshiro Fujita, et al.
Kidney International (2023) Vol. 104, Iss. 4, pp. 690-697
Open Access | Times Cited: 16
Protective effect of microbiota-derived short chain fatty acids on vascular dysfunction in mice with systemic lupus erythematosus induced by toll like receptor 7 activation
Javier Moleón, Cristina González‐Correa, Sofía Miñano, et al.
Pharmacological Research (2023) Vol. 198, pp. 106997-106997
Open Access | Times Cited: 16
Prospects for Leveraging the Microbiota as Medicine for Hypertension
David J. Durgan, Jasenka Zubcevic, Matam Vijay‐Kumar, et al.
Hypertension (2024) Vol. 81, Iss. 5, pp. 951-963
Open Access | Times Cited: 6
Perspective: Revisiting the Concepts of Prebiotic and Prebiotic Effect in Light of Scientific and Regulatory Progress – A Consensus Paper from the Global Prebiotic Association (GPA)
Edward C. Deehan, Santa Al Antwan, Rhonda S Witwer, et al.
Advances in Nutrition (2024) Vol. 15, Iss. 12, pp. 100329-100329
Open Access | Times Cited: 5
Maternal Diet and Gut Microbiota Influence Predisposition to Cardiovascular Disease in Offspring
Hamdi Jama, Malathi S.I. Dona, Evany Dinakis, et al.
Circulation Research (2024) Vol. 135, Iss. 4, pp. 537-539
Open Access | Times Cited: 4
Effects of Oral Butyrate on Blood Pressure in Patients With Hypertension: A Randomized, Placebo-Controlled Trial
Barbara J. H. Verhaar, Madelief Wijdeveld, Koen Wortelboer, et al.
Hypertension (2024) Vol. 81, Iss. 10, pp. 2124-2136
Open Access | Times Cited: 4
Constipation is associated with an increased risk of major adverse cardiac events in a UK population
Tenghao Zheng, Letícia Camargo Tavares, Mauro D’Amato, et al.
AJP Heart and Circulatory Physiology (2024) Vol. 327, Iss. 4, pp. H956-H964
Open Access | Times Cited: 4
Butyrate increases cardiac output and causes vasorelaxation in a healthy porcine model
Louisa Christensen, Alf Inge Larsen, Casper Homilius, et al.
Life Sciences (2025) Vol. 363, pp. 123407-123407
Open Access
The influence of microplastics on hypertension-associated cardiovascular injury via the modulation of gut microbiota
Siyuan Wang, Keying Yan, Ying Dong, et al.
Environmental Pollution (2025), pp. 125760-125760
Closed Access
Fiber, Fatty Acids, and Blood Pressure: A Gut-Level Solution
Mohd Mabood Khan, Annet Kirabo
Circulation Research (2025) Vol. 136, Iss. 4, pp. 358-360
Closed Access
Microbiome-Based Therapeutics for Salt-Sensitive Hypertension: A Scoping Review
Abdulwhab Shremo Msdi, Anahita Haghparast, Kevin W. Garey, et al.
Nutrients (2025) Vol. 17, Iss. 5, pp. 825-825
Open Access
Steric Inhibition by Butyryl Groups on Gut Microbial Amylases Significantly Impacts In Vitro Fecal Fermentation of Butyrylated Starch
Lingjin Li, Yi Zhang, Zehao Huang, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
Protective Effect of Dietary Fiber on Blood Pressure and Vascular Dysfunction Through Regulation of Sympathetic Tone and Immune Response in Genetic Hypertension
Cristina González‐Correa, Javier Moleón, Sofía Miñano, et al.
Phytotherapy Research (2025)
Closed Access
Page 1 - Next Page

Scroll to top